LOAN PHAM: Open Payments
NPI 1053440065 · FIFE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 10 payments from 7 companies in 2025. Trend: 2023 $126 · 2024 $618 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $362 |
| Otsuka America Pharmaceutical, Inc. | 2 | $266 |
| Amgen Inc. | 1 | $150 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $121 |
| Alexion Pharmaceuticals, Inc. | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
Products named: AUSTEDO XR, REPATHA, UZEDY, Auvelity, REXULTI, LYBALVI, ULTOMIRIS, AIRSUPRA.
Industry payments across WA — which companies pay providers there.
